Hess Lab | Development of rational approaches towards metal-containing antimicrobials

A 2023 Crick PhD project with Jeannine Hess. This application is open until 12:00 noon on 22 March 2023.
Deadline for applications has passed.

Key information

Applications closed
22 March 2023, 12:00 GMT
Posted 15 February 2023

Research topics

Biochemistry & Proteomics Chemical Biology & High Throughput Infectious Disease Structural Biology & Biophysics
Background texture taken from the lab imagery.

A 2023 Crick PhD project with Jeannine Hess.

Project background and description

Antibacterial drugs discovered several decades ago are the cornerstone of our modern healthcare settings allowing the treatment of previously life-threatening bacterial infections. However, with the emergency of pathogenic bacteria resistant to common antibiotics we are at serious risk of heading towards the pre-antibiotic era[1]. The newly established biological inorganic chemistry research group, led by Dr Jeannine Hess, is determined to develop new solutions to contain the upsurge of bacterial infections and antibacterial resistances. Moving beyond conventional drug discovery programs, we develop and apply target-based and structure-guided approaches (such as Fragment-Based Drug Discovery[2]) to generate drug candidates with new modes of action relying on the interplay of organic moieties and inorganic components[3].

We are looking for a highly motivated PhD student to design and apply new concepts to target microbial metalloenzymes[4] and to develop inorganic/organometallic chemical probes and antimicrobial drug candidates[5]. You will rely extensively on state-of-the-art chemical synthesis and analytical chemistry to generate new, rationally designed compounds with biological activity. You will also use and develop a variety of approaches for structural guidance to design the compounds and to test their biological activity. These include protein expression, a wide range of biophysical techniques such as differential scanning fluorimetry (DSF), ligand-based NMR spectroscopy, isothermal titration calorimetry (ITC), and in-vitro enzymatic assays.

Importantly, you will also help building and maintaining an open and collaborative lab atmosphere that nurtures scientific creativity and productivity, complementing our team on the mission towards new therapies against drug-resistant bacteria.

Candidate background

  • You are motivated to work at the forefront of antimicrobial discovery and to develop new approaches and strategies to generate inorganic or organometallic compounds with interesting biological activity
  • You have practical experience in organic synthesis, organometallic chemistry, medicinal chemistry, chemical biology, bioinorganic chemistry or any related field
  • You are creative, have excellent communication skills, are enthusiastic about working collaboratively in a multidisciplinary research area and are interested in learning and adopting relevant techniques to achieve the research goals



1.         Murray, C.J.L., Ikuta, K.S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., . . . Naghavi, M. (2022)

            Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

            The Lancet 399: 629-655. PubMed abstract

2.         Mashalidis, E.H., Śledź, P., Lang, S. and Abell, C. (2013)

            A three-stage biophysical screening cascade for fragment-based drug discovery.

            Nature Protocols 8: 2309-2324. PubMed abstract

3.         Hess, J. (2022)

            Rational approaches towards inorganic and organometallic antibacterials.

            Biological Chemistry 403: 363-375. PubMed abstract

4.         Chen, A.Y., Adamek, R.N., Dick, B.L., Credille, C.V., Morrison, C.N. and Cohen, S.M. (2019)

            Targeting metalloenzymes for therapeutic intervention.

            Chemical Reviews 119: 1323-1455. PubMed abstract

5.         Boros, E., Dyson, P.J. and Gasser, G. (2020)

            Classification of metal-based drugs according to their mechanisms of action.

            Chem 6: 41-60. PubMed abstract